急需同等资金来支持评估循证和指南推荐结直肠癌筛查试验的研究

The Imperative of Equal Funding for Studies That Evaluate Any of the Evidence-Based, Guideline-Recommended Colorectal Cancer Screening Tests
作者:James E. Allison 【全球专家评论】
期刊: CLIN GASTROENTEROL H2009年2月12期7卷

In colorectal (CRC) screening guidelines published before 2008, flexible sigmoidoscopy (FS) plus fecal occult blood test (FOBT) was a recommended option. In 2008 the American Cancer Society/US Multisociety Taskforce and American College of Radiology guidelines5 dropped this recommendation and the US Preventive Services guidelines (USPSTF)6 changed its recommendation to FS and high-sensitivity FOBT (Hemoccult Sensa [Beckman Coulter, Inc, Fullerton, CA] or Fecal Immunochemical Test [FIT]) every 5 years plus an interval high-sensitivity FOBT alone every 3 years from age 50 to age 75.6 The importance and impact of guidelines make it necessary to evaluate the evidence available to guideline maker


学科代码:消化病学 肿瘤学   关键词:急需同等资金来支持评估循证和指南推荐结直肠癌筛查试验的研究
顶一下(0
您可能感兴趣的文章
    发表评论网友评论(0)
      发表评论
      登录后方可发表评论,点击此处登录